Planned hematopoietic stem cell transplantation in a 17-month-old patient with high-risk acute myeloid leukemia and persistent SARS-CoV-2 infection.
作者信息
Cuzzubbo Daniela, Pegoraro Francesco, Frenos Stefano, Casini Tommaso, Galli Luisa, Gambineri Eleonora, Bambi Franco, Tintori Veronica, Favre Claudio
机构信息
Pediatric Haematology/Oncology and HSCT Department, Meyer Children's University Hospital, Florence, Italy.
Department of Health Science, University of Florence, Florence, Italy.
出版信息
Transfusion. 2021 May;61(5):1657-1659. doi: 10.1111/trf.16361. Epub 2021 Mar 25.
Abstract
摘要
相似文献
1
Planned hematopoietic stem cell transplantation in a 17-month-old patient with high-risk acute myeloid leukemia and persistent SARS-CoV-2 infection.一名17个月大的高危急性髓系白血病且持续感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的患者计划进行造血干细胞移植。
Transfusion. 2021 May;61(5):1657-1659. doi: 10.1111/trf.16361. Epub 2021 Mar 25.
2
Hematopoietic Stem Cell Transplantation to a Patient with Acute Myeloid Leukemia from a Sibling Donor Positive for SARS-CoV-2 by RT-PCR Test.对一名急性髓系白血病患者进行来自经逆转录聚合酶链反应（RT-PCR）检测SARS-CoV-2呈阳性的同胞供者的造血干细胞移植。
Turk J Haematol. 2022 Jun 1;39(2):150-151. doi: 10.4274/tjh.galenos.2022.2022.0086. Epub 2022 Apr 26.
3
COVID-19 after hematopoietic stem cell transplantation: report of two children.造血干细胞移植后发生的新型冠状病毒肺炎：两名儿童的病例报告
Bone Marrow Transplant. 2021 Mar;56(3):713-715. doi: 10.1038/s41409-020-01041-8. Epub 2020 Sep 16.
4
Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study.伊达比星强化的BUCY2预处理方案改善了接受异基因造血干细胞移植的高危急性髓系白血病患者的生存率，但对淋巴细胞白血病患者无效：一项回顾性比较研究。
Leuk Res. 2016 Jul;46:61-8. doi: 10.1016/j.leukres.2016.04.014. Epub 2016 Apr 19.
5
Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.异基因造血干细胞移植后巨细胞病毒再激活与移植后存活至第100天的急性髓系白血病患者复发风险降低相关：日本造血细胞移植学会移植相关并发症工作组
Biol Blood Marrow Transplant. 2015 Nov;21(11):2008-16. doi: 10.1016/j.bbmt.2015.07.019. Epub 2015 Jul 26.
6
Detection of SARS-CoV-2 viremia before onset of COVID-19 symptoms in an allo-transplanted patient with acute leukemia.一名急性白血病异基因移植患者在COVID-19症状出现前检测到SARS-CoV-2病毒血症。
Bone Marrow Transplant. 2021 Mar;56(3):716-719. doi: 10.1038/s41409-020-01059-y. Epub 2020 Sep 18.
7
Allogeneic Hematopoietic Stem Cell Transplantation for Children and Adolescents with Acute Myeloid Leukemia in Brazil: A Multicentric Retrospective Study.巴西儿童和青少年急性髓细胞白血病的异基因造血干细胞移植：一项多中心回顾性研究。
Cell Transplant. 2020 Jan-Dec;29:963689720949175. doi: 10.1177/0963689720949175.
8
Allogeneic stem cell transplantation in acute leukemia patients after COVID-19 infection.新型冠状病毒肺炎感染后急性白血病患者的异基因干细胞移植
Bone Marrow Transplant. 2021 Jun;56(6):1478-1481. doi: 10.1038/s41409-021-01225-w. Epub 2021 Feb 9.
9
Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study.急性髓系白血病异基因造血干细胞移植中清髓性与减低强度预处理方案的比较：一项队列研究
Turk J Haematol. 2019 May 3;36(2):88-96. doi: 10.4274/tjh.galenos.2019.2018.0220. Epub 2019 Feb 5.
10
Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study.在基于 BU 的清髓性造血干细胞移植中，未处理的单倍体相合、匹配的无关供体和匹配的同胞供体在完全缓解的中危和高危急性髓系白血病中的结果相当：一项单中心研究。
Ann Hematol. 2021 Jun;100(6):1579-1591. doi: 10.1007/s00277-020-04355-1. Epub 2020 Nov 24.
引用本文的文献
1
COVID-19 infection in children with blood cancer: A systematic review.血癌患儿的新冠病毒感染：一项系统综述
Ann Hematol. 2025 Feb;104(2):1203-1230. doi: 10.1007/s00277-024-06057-4. Epub 2024 Nov 5.
2
Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia in a Pediatric Patient After COVID-19 Infection Complicated by MIS-C.COVID-19 感染后合并 MIS-C 的儿科患者的异基因造血干细胞移植治疗急性淋巴细胞白血病。
J Pediatr Health Care. 2022 May-Jun;36(3):280-285. doi: 10.1016/j.pedhc.2022.01.006. Epub 2022 Jan 31.
本文引用的文献
1
The great challenge of managing recipients of hematopoietic stem cell transplantation combined with COVID-19.管理造血干细胞移植合并 COVID-19 患者的巨大挑战。
Bone Marrow Transplant. 2021 Mar;56(3):696-700. doi: 10.1038/s41409-020-01035-6. Epub 2020 Aug 25.
2
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.新冠康复者血浆或高效免疫球蛋白用于新冠患者：一项实时系统评价
Cochrane Database Syst Rev. 2020 Jul 10;7(7):CD013600. doi: 10.1002/14651858.CD013600.pub2.
3
Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression.一名患有急性髓系白血病且因治疗导致严重免疫抑制的1岁女童新冠病毒病2019的良好转归。
Br J Haematol. 2020 Jun;189(6):e222-e224. doi: 10.1111/bjh.16781. Epub 2020 May 19.
4
Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic.癌症、COVID-19 和预防原则：在全球大流行期间优先考虑治疗。
Nat Rev Clin Oncol. 2020 May;17(5):268-270. doi: 10.1038/s41571-020-0362-6.
5
Risk of COVID-19 for patients with cancer.癌症患者感染新型冠状病毒肺炎的风险。
Lancet Oncol. 2020 Apr;21(4):e180. doi: 10.1016/S1470-2045(20)30150-9. Epub 2020 Mar 3.
Zotero 插件